SCHEMBL196575

SCHEMBL196575

CCCCOCc1ccc(-c2ccc(COCCCC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.47
CYP3A4 P08684 3/20 0.46
CYP2D6 P10635 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
RARB P10826 4/20 0.44
BDKRB2 P30411 3/20 0.42
HRH4 Q9H3N8 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
CYP19A1 P11511 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP1A2 P05177 1/20 0.42
RARA P10276 1/20 0.41
GBA1 P04062 1/20 0.39
UGCG Q16739 1/20 0.39
GBA2 Q9HCG7 1/20 0.39
PLA2G4B P0C869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL647523 0.93 L3MBTL1 (0.49) NAAACYP3A4L3MBTL1TDP1PLA2G4B
SCHEMBL9750481 0.87 L3MBTL1 (0.45) NAAACYP3A4CYP2D6L3MBTL1TDP1
SCHEMBL5599359 0.86 NAAA (0.42) NAAACYP3A4CYP2D6L3MBTL1TDP1
SCHEMBL8730821 0.86 CHRNB2 (0.40) NAAACYP3A4CYP2D6L3MBTL1TDP1
SCHEMBL8725398 0.86 CHRNB2 (0.40) NAAACYP3A4CYP2D6L3MBTL1TDP1
SCHEMBL8732536 0.86 CNR2 (0.49) NAAACYP3A4CYP2D6L3MBTL1TDP1
SCHEMBL1839898 0.85 LTA4H (0.55) CYP3A4CYP2D6L3MBTL1TDP1CYP2C19
SCHEMBL9073374 0.85 AGXT (0.48) L3MBTL1TDP1GBA1UGCGGBA2
SCHEMBL8728394 0.85 CYP3A4 (0.41) NAAACYP3A4CYP2D6L3MBTL1TDP1
SCHEMBL8728393 0.85 CYP3A4 (0.41) NAAACYP3A4CYP2D6L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023063122-A1 CURABLE RESIN COMPOSITION, PREPREG, AND CURED PRODUCT OF SAME 日本化薬株式会社 2023-04-20 WO disclosed
CN-108884302-B Thermosetting resin composition, prepreg, and cured product thereof 日本化药株式会社 2023-03-28 CN disclosed
CN-108884302-A Heat-curing resin constituent, prepreg and their solidfied material 日本化药株式会社 2018-11-23 CN disclosed
CN-108884212-A Maleimide resin, hardening resin composition and its hardening thing 日本化药株式会社 2018-11-23 CN disclosed
CN-107614567-A EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF 日本化药株式会社 2018-01-19 CN disclosed
US-20170369636-A1 Aromatic Amine Resin, Epoxy Resin Composition And Cured Product Thereof NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2017-12-28 US disclosed
EP-3248996-A1 AROMATIC AMINE RESIN, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF Nippon Kayaku Kabushiki Kaisha (JP) 2017-11-29 EP disclosed
EP-2390241-B1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2014-10-01 EP disclosed
US-8598349-B2 Method for manufacturing conjugated aromatic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-12-03 US disclosed
US-8293905-B2 Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-23 US disclosed
EP-2390241-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND Sumitomo Chemical Company, Limited (JP) 2011-11-30 EP disclosed
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2011-11-10 US disclosed
US-20110256790-A1 THERMAL INSULATION CONTAINING SUPPLEMENTAL INFRARED RADIATION ABSORBING MATERIAL SAINT-GOBAIN ISOVER (FR) 2011-10-20 US disclosed
US-20110046336-A1 TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX SUMITOMO CHEMICAL COMPANY, LIMITED 2011-02-24 US disclosed
US-20100292481-A1 METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2010-11-18 US disclosed
EP-2233459-A1 METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-09-29 EP disclosed
US-20100184978-A1 BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-07-22 US disclosed
EP-2192124-A1 TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND WITH THE TRANSITION METAL COMPLEX Sumitomo Chemical Company, Limited (JP) 2010-06-02 EP disclosed
EP-2172470-A1 BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX Sumitomo Chemical Company, Limited (JP) 2010-04-07 EP disclosed
US-4163731-A HYDRAULIC FLUIDS CIBA-GEIGY AG (CH) 1979-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369636-A1 Aromatic Amine Resin, Epoxy Resin Composition And Cured Product Thereof H1-5, ASH2L, ASH1L NAAA 595/4885CYP3A4 2143/4885CYP2D6 3416/4885
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND C9, H1-10, CYP1A1 NAAA 2359/4885CYP3A4 497/4885CYP2D6 323/4885
US-20110046336-A1 TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX C9, C5, AP1M1 NAAA 3358/4885CYP3A4 61/4885CYP2D6 543/4885
US-20100184978-A1 BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX C9, C5, AP2M1 NAAA 3386/4885CYP3A4 135/4885CYP2D6 209/4885
US-20100292481-A1 METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND TYR, PAH, AHR NAAA 72/4885CYP3A4 956/4885CYP2D6 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.